The Green Organic Dutchman Holdings Ltd. (TSX: TGO
Post# of 179
- Canaccord Genuity initiates coverage of TGOD with C$7.00 price target
- TGOD expands international footprint to 17 countries with joint venture In Mexico
- Appoints new CFO, strengthens marketing and compliance with senior appointments
Canaccord Genuity has turned bullish on The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), and its reasons are set out in an initiation report. The Canadian producer of organic cannabis is set for international expansion, say analysts from the investment bank’s research division. They have initiated coverage with a “Speculative Buy” rating and a price target of C$7.00 ($5.40), which is almost double the present value of the company’s shares (http://nnw.fm/p87HF). TGOD, they say, has enough cash “to achieve annual capacity of approximately 195,000 kg (excluding hemp production).” Some of that production may make its way to Mexico under a joint venture agreement, as the company continues to expand its international footprint. To run the show, TGOD is bringing in new talent. It now has a new CFO and has made appointments, at a senior level, in compliance and marketing.
The Canaccord Genuity analysts believe that a major differentiating factor for TGOD is its focus on organic cannabis, which is preferred, according to a recent survey, by “43 percent of Canadian recreational cannabis consumers.” They “expect the negative impact of consuming cannabis containing pesticides will continue to generate strong demand for organic product.” As a result, they “estimate that Green Organic Dutchman’s fully funded production capacity translates to approximately $1.1-1.4 billion in annual revenue. While TGOD’s current focus is on increasing production capacity in Ontario and Quebec, (they) expect the company to be free cash flow positive in 2020 as it plans to build a portfolio of organic cannabis brands that will serve legal recreational and medical markets around the world.” TGOD now has operations in 17 countries spanning two continents and revolving around CBD oil, which, unlike THC, is generally legal in those countries. In Mexico, for instance, pharmacological derivatives of cannabis have been legal since June 19, 2017.
In October 2018, TGOD announced that it had entered into a strategic joint venture with LLACA Grupo Empresarial to create a 50/50-owned company to enter the medicinal cannabis market in Mexico (http://nnw.fm/0w1aN). LLACA will facilitate the importation, registration and distribution of TGOD-branded organic cannabis and hemp-derived medical products into the Mexican market. LLACA brings formidable capability to the partnership. Through its distribution network, TGOD will have access to 4,500 pharmacies and 3,100 supermarkets throughout Mexico.
To tackle the challenges from international expansion, TGOD is boosting its organizational capabilities. In October 2018, the company announced the appointment of Sean Bovingdon as its new chief financial officer (http://nnw.fm/YZDg9). Bovingdon is an accomplished executive with almost 30 years’ experience in a variety of private and public companies. Most recently, he served as CFO of Toronto Hydro Corporation, a utility company with $3.5 billion in annual revenue. Before that, he served as president and CFO of a number of public and private oil and gas companies; as CFO and VP, finance for TSX-listed technology and manufacturing companies; and as controller for a major TSX-listed oil sands company. Bovingdon has been involved in $1.1 billion of public equity and debt financings and $2 billion of syndicated credit facilities, including three IPOs.
TGOD further strengthened its senior management team with two new appointments: Emily Demeo as its marketing brand director and Terry Reid as its director, legal and compliance. Demeo has joined from Molson Coors Canada (MCC), where she led MCC’s foray into non-alcoholic beverages, gaining valuable marketing experience in a regulated industry. Before her stint at MCC, Demeo worked at L’Oreal as senior product manager for Garnier Fructis.
Reid joins TGOD following a successful career at Teva Pharmaceuticals, where he was a key member of both the legal and compliance teams, most recently as head of compliance for Canada. Prior to his role at Teva, Reid had a successful commercial litigation practice at a reputable Toronto law firm.
For more information, visit the company’s website at www.TGOD.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer